About Canary Medical
Millions of people around the world rely on medical implants but once the last suture is closed, these devices are instantly silenced.
Canary creates a voice for medical implants by allowing them to generate and share data.
With our CANARY canturioTM and SummatixTM products, Canary opens the door to entirely new opportunities to improve patient outcomes and lower the cost of care by enabling devices to self-report data on patients’ conditions, and in addition, CanturioTM and Summatix manage, analyze, and access the data in a manner that supports the reimbursement requirements for Remote Patient Monitoring (RPM).
Smart, talking medical implants, and the data services required to use the insights they generate, provide clinicians with entirely new sources of relevant, accurate and timely information that offer greater visibility and connectivity to patient health.
To give medical implants a voice, and to let the medical data they gather be heard, Canary has developed a novel and unparalleled platform to achieve greater visibility and connectivity to patient health. Canary technologies are covered by over 80 granted and pending patents. To learn more about our solution hover over the elements below:
CanturioTM is a SMART medical device that integrates with other standard medical devices to collect data on the patient’s mobility.
SummatixTM is a wholly owned data management subsidiary that aggregates, analyzes, and provides appropriate and relevant access to medical data.
Canturio first implementation
Canturio is Latin for “chirping”, or “singing continuously.” CANARY canturio products give medical devices the voice to communicate objective data that can remotely inform on a patient’s physiological condition supporting a wide range of therapeutic applications.
Canary’s first product, the canturioTMte, is a modified tibial extension for use with Zimmer Biomet’s Persona® prosthetic knee joint, the first orthopedic prosthetic joint implant designated a Breakthrough Device by FDA and submitted for regulatory review for market clearance with FDA Breakthrough Status.
The canturio te is a breakthrough with its sophisticated collection of technology: an IMU sensor with a 3D-accelerometer, 3D-gyroscope and pedometer; a memory board; a communications array; and a battery with 20 years of capacity. The canturio te measures and records joint range of motion and patient activity with unrivaled accuracy and reliability, providing an entirely new tool to help manage prosthetic knee post-surgical recovery.
Developing the canturio te demonstrated what components Canturio products need to give medical devices a voice across other therapeutic areas: sensors, communications, power. A voice is not enough, however, the data has to be heard. This is where Canary’s platform solution, Summatix, comes in.
To be useful, medical data generated from medical devices must be heard. To be heard, a platform needed to be developed to securely transmit data from an implant, make its raw sensor data clinically relevant, and make that data available to the patients and healthcare providers who need it.
Only from this kind of ecosystem can the promise of dramatic improvements in the timeliness and personalization of patient be delivered. That is why Canary established Summatix, a wholly owned data management subsidiary that aggregates, analyzes, and provides appropriate and relevant access to medical data.
The Summatix platform provides more than just access to medical data: it integrates the rigorous requirements of the Common Procedural Terminology (CPT) codes from the Center for Medicaid and Medicare Services (CMS) that allow clinicians to be reimbursed for Remote Patient Monitoring (RPM). Canary has programmed the canturio te and designed the Summatix analytical algorithms and clinician interface to meet these highly specific requirements, and to be able to adapt, should they change. As a result, clinicians treating patients fitted with the canturio te may be effectively reimbursed for using the insights arising from the data it generates.
Just as building the canturio te revealed Canturio to be an extensible solution for medical devices, creating the infrastructure needed to meet reimbursement requirements revealed Summatix to be an extensible data and practice management platform. Summatix can readily serve as a conduit for data not only from other Canturio products, but from other manufacturers’ qualified SMART devices that collect clinically relevant data required for RPM-based care.
Canary, through Summatix, can manage and process this data in much the same way it does for data from canturio te. And that is how Canary lets medical data be heard. Visit summatix.com for more information.